Evidence Matrix: Clinical Claims from TEV Research Wiki¶
Total claims extracted: 120+ across 15 source files Date of extraction: 2026-05-20
Domain 1 — Root Cause: Adult Complications of Childhood Clubfoot Surgery¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 1.1 | PMR 30-year outcomes: 0% excellent, 47% poor, 73% fair/poor | Dobbs et al. 2006, PMID 16651573 | III | HIGH | Single landmark study | Full-text verified 2026-05-19; previously cited incorrectly as "30% fair/poor" |
| 1.2 | PMR reoperation rate: 87% of patients required additional surgery beyond index | Dobbs et al. 2006, PMID 16651573 | III | HIGH | Single study | Full-text verified |
| 1.3 | PMR degenerative changes: 56% radiographic OA at 30 years | Dobbs et al. 2006, PMID 16651573 | III | HIGH | Confirmed by multiple series | Previously cited as 74%—corrected after full-text verification |
| 1.4 | PMR SF-36 Physical Component Score: 33.65 (vs population norm 50) | Dobbs et al. 2006, PMID 16651573 | III | HIGH | Single study | Comparable to Parkinson's, CKD, CHF patients |
| 1.5 | Cooper/Dietz 30-year follow-up: 78% good/excellent clinical results | Cooper/Dietz 1995, PMID 7593056 | III | MODERATE | Single cohort | 66% OA rate unverified—full-text extraction failed to locate figure |
| 1.6 | Ponseti group had greater plantarflexion ROM (p<0.001), strength, and less OA vs surgical group | Smith/Kuo 2014, PMID 24249539 | III | HIGH | Confirmed by multiple studies | Direct head-to-head comparison, 42 adults + 48 controls |
| 1.7 | Pain elevated in surgical vs Ponseti group (p=0.008) | Smith/Kuo 2014, PMID 24249539 | III | HIGH | Replicated in ~25yr follow-up | SF-36 Bodily Pain domain |
| 1.8 | Surgical gait: reduced walking speed 1.01 vs 1.18 m/s (p<0.0001) | Smith/Kuo 2014, PMC3940756 | III | HIGH | Full-text verified | Table 4 confirmed in full-text |
| 1.9 | Surgical gait: increased double support time 30% vs 24% (p<0.0001) | Smith/Kuo 2014, PMC3940756 | III | HIGH | Full-text verified | Hallmark of pain avoidance/instability |
| 1.10 | 90% of clubfoot limbs have congenital anterior tibial artery deficiency | Springer chapter (unverified) | V | LOW | Single anatomical source | Mechanism-based reasoning |
| 1.11 | Overcorrection accounts for 70% of inferior PMR results | Zide/Myerson 2013 | V | LOW | Expert opinion | Level V—expert opinion, not quantified |
| 1.12 | McKay procedure: 100% abnormal talar findings | Pinto/Hernandes | IV | MODERATE | Single case series | Suggests universal talar distortion |
| 1.13 | McKay vs Turco: 89.47% vs 72.22% satisfactory | Hossain/Musa 2024 | III | MODERATE | Single comparative study | Citation origin uncertain |
| 1.14 | CSTR progressive functional deterioration with longer follow-up | French CSTR follow-up 2011, PMID 20864856 | IV | MODERATE | Replicated across series | Consistent with Dobbs decompensation model |
| 1.15 | PMR 20-year follow-up: 75% good clinical results, but overcorrection in 6/41, undercorrection in 4/41 | Kránicz et al. 1998, PMID 9642705 | IV | MODERATE | Single series | Short-term good results mask long-term decline |
| 1.16 | Peroneal nerve dysfunction: 8/837 (0.7%) in complex clubfeet | Yoshioka 2010, PMID 21045967 | IV | MODERATE | Single study | Not general population; only complex cases |
| 1.17 | Flat-top talus occurs in both Ponseti and surgical groups; Ponseti more protective (RR=0.494, p=0.002) | PMID 32982254 | III | MODERATE | Single comparative study | Complication of over-manipulation |
| 1.18 | Double arthrodesis late sequelae: adjacent joint degeneration common | 2008 series, PMID unverified | IV | MODERATE | Replicated across multiple series | Consistent clinical finding |
| 1.19 | 2024 Ponseti meta-analysis: Ponseti superior to surgical across multiple outcomes | MDPI Children 2024 | I | HIGH | Meta-analysis of multiple studies | Highest evidence level in TEV literature |
| 1.20 | Ponseti vs French 2009: 37% vs 29% relapse rates (not statistically significant per authors) | Faulks/Richards 2009, PMID 19242767 | V | MODERATE | Single study (corrected to Level V) | Paper self-reports Level V, wiki incorrectly cited as Level II |
Domain 2 — Diagnosis & Assessment¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 2.1 | Weight-bearing X-rays essential—non-weight-bearing underestimates deformity | Clinical standard | V | HIGH | Universal clinical consensus | Multiple sources CORRECTED—many citations pointed to wrong papers |
| 2.2 | Pedobarography is most predictive tool for wound recurrence risk | General clinical practice | V | EXTRAPOLATED | From diabetic foot literature | No direct study in post-surgical clubfoot |
| 2.3 | WIfI classification more appropriate than Wagner for post-surgical feet | Mills et al. 2014, PMID 24126108 | IIb | EXTRAPOLATED | Validated in CLTI, not clubfoot | Incorporates ischemia—critical for scarred vasculature |
| 2.4 | Multidisciplinary assessment mandatory (ortho, vascular, wound, PM&R) | Clinical consensus | V | HIGH | Standard of care | PMC9534229 corrected—is about pediatric relapse, NOT team composition |
| 2.5 | CT with 3D reconstruction essential for surgical planning | Clinical practice | V | HIGH | Universal consensus | Multiple CORRECTED citations—original citations pointed to irrelevant papers |
| 2.6 | ABI may be falsely normal in post-surgical feet due to medial calcification | ACC/AHA guidelines | I | EXTRAPOLATED | Well-established in PAD | TBI needed for accurate assessment |
| 2.7 | TcPO2 <30 mmHg suggests impaired wound healing; <20 mmHg contraindicates surgery without revascularization | Conte et al. 2019 GVG | I | EXTRAPOLATED | Established in wound care | From CLTI literature, applies to non-diabetic wounds |
| 2.8 | Bilateral assessment critical—both feet must be evaluated independently | Clinical practice | V | HIGH | Universal principle | Each foot may have different deformity pattern |
Domain 3 — Wound Care & Ulcer Management¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 3.1 | Post-clubfoot wounds = mechanical pathology distinct from diabetic ulcers | Domain synthesis | V | HIGH | Mechanistic reasoning | Root cause is deformity, NOT neuropathy/metabolic |
| 3.2 | TCC is gold standard offloading: 89.5% healed at 12 weeks | Armstrong et al. 2001, PMID 11375363 | II | EXTRAPOLATED | Confirmed in multiple DFU RCTs | From diabetic ulcer literature; only clinical extension to non-diabetic |
| 3.3 | TCC reduces plantar pressure by 70-80% at ulcer site | Multiple systematic reviews | I | EXTRAPOLATED | Well-established | From DFU literature |
| 3.4 | Custom therapeutic footwear reduces recurrence by ~50% | Bus et al. 2016 IWGDF, PMID 26813614 | I | EXTRAPOLATED | IWGDF guideline | DFU-specific but biomechanical principle generalizes |
| 3.5 | NPWT: moderate-quality evidence for improved healing | PMC4110388 (narrative review) | IV | MODERATE | Multiple studies | CORRECTED—not a Cochrane Review as stated |
| 3.6 | PRP: autologous PRP delivers concentrated growth factors; meta-analysis shows improved healing | PMC12795992 | III | MODERATE | Multiple meta-analyses | Specific "56% >90% reduction at 4 weeks" stat not found in cited paper |
| 3.7 | Stem cell therapy: RR 1.67 for complete healing (28 RCTs) | Chiang et al. 2021, PMID 34943815 | I | EXTRAPOLATED | Meta-analysis of RCTs | In DFU population; extrapolated to structural wounds |
| 3.8 | AMG0001 gene therapy: median healing time 84 vs 280 days placebo (p=0.007) | LEGenD-1, PMID 41186002 | II | EXTRAPOLATED | Single RCT | In CLTI patients with neuroischemic ulcers, not structural deformity |
| 3.9 | AMG0001 12-month healing: 77.6% vs 46.2% (p=0.010) | LEGenD-1, PMID 41186002 | II | EXTRAPOLATED | Single RCT | P-value corrected from.033 to.010 per original paper |
| 3.10 | Offloading is the single most critical wound intervention | IWGDF guidelines | I | HIGH | Universal consensus | Wound treatment without pressure elimination is futile |
| 3.11 | Most wound care evidence is from diabetic populations—caution when applying to structural wounds | independent evidence review | V | HIGH | Identified gap | Critical limitation in applying DFU studies to post-clubfoot |
Domain 4 — Surgical Correction¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 4.1 | Triple arthrodesis is gold-standard salvage for adult clubfoot | Zhuang 2019, Maier 2023, King 2019 | IV | HIGH | Multiple case series | Largest series: King 2019 (442 ft/397 pts) |
| 4.2 | Triple arthrodesis: 81-100% patient satisfaction in clubfoot populations | Zhuang 2019, Maier 2023 | IV | MODERATE | Multiple series | Homogeneous retrospective data |
| 4.3 | Triple arthrodesis nonunion: 4.5-11% (TN joint highest risk) | King 2019, Maier 2023 | IV | MODERATE | Confirmed across series | King 2019: 4.5% clinical nonunion |
| 4.4 | Only 6.1% of adult clubfoot patients require arthrodesis; peak age 55-74 | Zhuang 2019 | IV | MODERATE | Single systematic review | De-identified age range claim corrected—not in original paper |
| 4.5 | Adjacent joint degeneration after triple: 44-72% in long-term series; King 2019 found no sig difference at 1.6yr | Multiple series | IV | MODERATE | Conflicting data | King's short follow-up may undercapture late change |
| 4.6 | Arthroscopic ankle fusion: OR 0.47 for complications vs open; 2.29 days shorter stay | Lorente et al. 2023, PMID 37240680 | II | MODERATE | Systematic review | CORRECTED from Level I to Level II |
| 4.7 | Percutaneous ankle fusion: 96.3% fusion at 3 months; VAS 7.4→0.2 | Marciano et al. 2023, PMC10272655 | IV | MODERATE | Single surgeon cohort | Excluded prior hindfoot procedures |
| 4.8 | LEAP study: no significant outcome difference salvage vs amputation at 2yr (SIP 12.6 vs 11.8, p=0.53) | MacKenzie/Bosse 2002-2005 | II | EXTRAPOLATED | Multicenter prospective | In trauma, not clubfoot; general principles apply |
| 4.9 | Smoking: 37% less likely to achieve union; 2.2x infection risk | LEAP study | II | EXTRAPOLATED | Well-established | Strong association confirmed across orthopedic literature |
| 4.10 | MESS >=7: 100% predicted amputation in validation; LEAP found limited clinical utility | Johansen 1990; LEAP | III | MODERATE | Conflicting validation | LEAP found insufficient sensitivity at individual level |
| 4.11 | TAA for clubfoot: 90% success modern implants; Fijany 2023 case successful at 6mo (pain 0-1/10) | Fijany 2023, PMC10558358 | IV | LOW | Single case report | Orthoplastic approach (TAA + free flap) |
| 4.12 | Revision clubfoot surgery: 62.5-77% excellent/good; Atar 28→74 (p<0.001) | Marinelli 2022, Ettl 2009 | IV | MODERATE | Two case series | 15 ft and 57 ft respectively |
| 4.13 | BOFAS 2023: single midfoot osteotomy + TAL; AOFAS 37.7→80.7 (p<0.05); 90% satisfied | Nogdallah 2023, BOFAS | IV | MODERATE | Single podium presentation | Cross-sectional, mean age 19.9 yrs |
| 4.14 | Ilizarov/TSF: 81.4% pooled success; 19.6-27% pin tract infection | Vaccalluzzo et al. 2025, PMID 39932573 | IV | MODERATE | Meta-analysis of case series | CORRECTED from Level V to Level IV |
Domain 5 — Vascular & Neurological Complications¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 5.1 | PMR surgery compromises both arterial supply and venous drainage through scar and altered anatomy | Anatomical/surgical literature | V | MODERATE | Mechanistic reasoning | No direct study measuring post-PMR perfusion |
| 5.2 | BASIL-2: endo-first superior to bypass-first for IP revascularization (35% reduced amputation/death) | Bradbury et al. 2023, PMID 37116524 | Ib | EXTRAPOLATED | Large multicenter RCT | CLTI population; CORRECTED author attribution |
| 5.3 | WIfI classification predicts 1-year amputation risk | Mills et al. 2014, PMID 24126108 | IIb | EXTRAPOLATED | Validated in CLTI | Beropoulis 2016 confirmed in nondiabetic CLTI |
| 5.4 | Tarsal tunnel decompression: 75.3% excellent/good results | Haq et al. 2024, PMC11296061 | IIb | MODERATE | Systematic review of 32 studies | In general population, not specific to post-PMR |
| 5.5 | Peroneal nerve decompression: 85% motor improvement, 84% pain improvement | King et al. 2024, PMC11449461 | III | MODERATE | Single case series | 46 patients, 47 limbs |
| 5.6 | Lumbar sympathectomy: limited efficacy (39-45% wound healing) when revascularization not possible | Wardak et al. 2026, PMID 41254237 | IV | MODERATE | Systematic review of 16 studies | Last-resort option |
| 5.7 | Microvascular free flap: 91% flap survival, 86% 1-year limb salvage | Shimbo et al. 2023, PMID 36577499 | IIa | EXTRAPOLATED | Meta-analysis 15 studies | In CLTI with combined revascularization |
| 5.8 | Pregabalin superior to gabapentin for neuropathic pain VAS (SMD -0.47, 95% CI -0.74 to -0.19) | Mayoral et al. 2025, PMC11747324 | I | EXTRAPOLATED | Meta-analysis 14 studies, 3,346 patients | From general neuropathic pain population |
| 5.9 | No studies exist on vascular outcomes in non-diabetic post-surgical foot wounds | expert review | V | HIGH | Identified research gap | All wound healing literature focuses on diabetic/atherosclerotic |
| 5.10 | BEST-CLI trial: open bypass superior to endovascular for clinical failure (HR 0.65, p<0.001) | Menard et al. 2024, PMC11734614 | Ib | EXTRAPOLATED | Large multicenter RCT | N=1830; vein graft cohort had 35% RRR |
Domain 6 — Rehabilitation & Conservative Management¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 6.1 | Custom orthoses better than prefabricated for complex deformity (40% better outcomes) | Patel et al. 2023 | II | MODERATE | Single RCT | Only one RCT directly addresses this |
| 6.2 | FES and AFO produce equivalent walking speed improvements for foot drop (MD 0.01 m/s, p=0.79) | Prenton et al. 2018, PMID 29227525 | Ia | EXTRAPOLATED | Meta-analysis 7 RCTs | In stroke population; extrapolated to clubfoot |
| 6.3 | Pregabalin shows better QoL improvement than gabapentin (SMD 0.39, 95% CI 0.11-0.68) | Mayoral et al. 2025, PMC11747324 | I | EXTRAPOLATED | Meta-analysis | General neuropathic pain population |
| 6.4 | Staged NMES→FES: 10mWT 27.1s→11.2s, TUG 29s→19s, VAS fear 6.7→0.4 | Yanagida et al. 2025, PMC12245141 | IV | LOW | Single case report | Lumbar stenosis foot drop, not clubfoot |
| 6.5 | Gait speed <0.8 m/s = elevated disability risk; stride length 0.64 m = falls predictor | Brognara et al. 2024, PMC11548473 | IIa | EXTRAPOLATED | Comprehensive review | General elderly/gait impairment population |
| 6.6 | Exoskeleton-assisted gait: limited evidence in musculoskeletal foot deformity; most data from stroke/SCI | Multiple sources | IIb-IV | LOW | Extrapolated only | No direct clubfoot studies |
| 6.7 | T-FLEX exoskeleton: 70% ankle ROM changes; GDI improved 30% paretic, 40% non-paretic | Gomez-Vargas et al. 2021, PMC8064364 | III | LOW | Single study in stroke | All specs verified against full-text |
| 6.8 | Capsaicin 8% patch: 12-week pain relief per application | FDA-approved labeling | I | EXTRAPOLATED | Multiple RCTs | Post-herpetic neuralgia evidence; applied to focal neuropathic pain |
| 6.9 | No adult clubfoot-specific rehab protocols exist | Domain synthesis | V | HIGH | Identified research gap | All PT protocols derived from general foot/ankle or neuro rehab |
| 6.10 | Structured foot rehab (Sharath 2024): VAS 7→2, FAAM 50%→97% in 2 months | Sharath et al. 2024, PMC11129531 | IV | LOW | Case series (n=2) | Flatfoot and pes cavus, 4-week exercise protocol |
Domain 7 — Emerging & Experimental Treatments¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 7.1 | No active interventional trials for non-diabetic chronic foot wounds in post-clubfoot adults | ClinicalTrials.gov search | V | HIGH | Identified gap | All wound-healing trials focus on DFU/VLU/PU |
| 7.2 | Umbilical review 2026: stem cell therapy promising adjunct for chronic lower extremity ulcers | PMC12831329 | IIb | EXTRAPOLATED | Umbrella review of SRs/MAs | Promising but no RCTs in structural wounds |
| 7.3 | AD-MSCs optimal cell source due to abundant supply and pro-angiogenic secretion | Farabi et al. 2024, PMC10931571 | IIb | EXTRAPOLATED | Systematic review of 44 studies | Demonstrated efficacy in PAD, diabetic, VLU, post-surgical wounds |
| 7.4 | CAP: antimicrobial + pro-proliferative; German S2k guideline recommends for chronic wounds | Raissi-Dehkordi et al. 2025, Frontiers Med | IIb | MODERATE | Multiple RCTs + guideline | Four verified mechanisms (ROS/RNS, IL-6/8, VEGF, COL1a) |
| 7.5 | TOT/CDO: strongest formal evidence (WHS Level 1, ADA Grade A, IWGDF recommend) | WHS Dec 2023, ADA 2024/2025, IWGDF 2023 | I | EXTRAPOLATED | Multiple guidelines | CMS explicitly does NOT cover (LCD L37873); $1,000-2,500/mo rental |
| 7.6 | Electrical stimulation (HVPC): pressure injuries RR 1.99 (Cochrane 2020, 11 RCTs, n=512) | WHAM Evidence Summary 2024 | I | EXTRAPOLATED | Cochrane review | DFU: SMD 2.56; all chronic wounds: SMD 0.72 |
| 7.7 | PEP exosome: Phase 2a completed (n=59); FDA Fast Track Jan 2026 | NCT06319287, BusinessWire | IIb | MODERATE | Single Phase 2a trial | CORRECTED: NCT06964048 shows NOT_YET_RECRUITING; no FDA-approved exosome product exists |
| 7.8 | 3D bioprinted skin: first-in-human clinical trials May 2025 (LIGO system, Australia) | NSW Health 2025 | IV | LOW | First-in-human trial | 2028-2032 for limited clinical use |
| 7.9 | AI wound assessment tools (MolecuLight, Tissue Analytics, Swift) are FDA-cleared and available NOW | FDA databases | IIb | MODERATE | Multiple FDA clearances | Most immediately actionable finding in Domain 7 |
| 7.10 | PBM/LLLT: positive effects on wound healing and pain reduction (18 RCTs, 670 wounds) | Taha 2024, PMC11602420 | I | EXTRAPOLATED | Meta-analysis | DFU benefit; VLU: no statistical benefit (high heterogeneity) |
Domain 8 — Specialists & Centers of Excellence¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 8.1 | UW/Harborview is strongest PNW option for complex foot/ankle reconstruction | Institutional websites | V | MODERATE | Grey literature | Contact details are institutional, not peer-reviewed |
| 8.2 | Only one named adult clubfoot doctor on nosurgery4clubfoot.com: Dr. James Meeker (OHSU) | nosurgery4clubfoot.com | V | MODERATE | Single directory listing | Most listed doctors are pediatric |
| 8.3 | No dedicated adult clubfoot registry exists | Domain synthesis | V | HIGH | Identified gap | Outcomes data is retrospective and fragmented |
| 8.4 | Fijany 2023 TAA in relapsed clubfoot = from Vanderbilt/TCU, NOT HSS | PMC10558358 full-text | IV | MODERATE | Full-text corrected | CORRECTED from original misattribution |
| 8.5 | AOFAS Find-a-Surgeon tool lists all fellowship-trained foot/ankle ortho surgeons | aofas.org | V | HIGH | Official directory | Best tool for finding adult reconstruction specialist |
| 8.6 | Shriners is pediatric-only — cannot treat new adult patients | Institutional policy | V | HIGH | Clear policy | Transition programs prepare patients ages 12+ for adult providers |
Domain 9 — Medical-Legal & Historical Context¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 9.1 | Turco PMR (1971) was era-appropriate standard of care; surgery in 1970s NOT malpractice | Turco 1971 PMID 5580007, Turco 1979 PMID 479227 | IV | HIGH | Multiple publications | Standard of care at time; Ponseti not standard until late 1990s |
| 9.2 | Ponseti method existed but was NOT standard of care in US until mid-to-late 1990s | Dobbs/Khan 2010 PMC2824215, NPR 2014 | III | HIGH | Documentary/historical record | Parent internet advocacy was primary adoption driver |
| 9.3 | Ponseti initial correction >90% in idiopathic clubfeet | Network meta-analysis PMID 38015923 | I | HIGH | Meta-analysis of RCTs | Global gold standard since ~2005-2010 |
| 9.4 | Dobbs 2006 SF-36 score 33.65 comparable to Parkinson's, CKD, pre-CABG patients | Dobbs et al. 2006, PMID 16651573 | III | HIGH | Single landmark study | Stark quantification of surgical-era disability |
| 9.5 | Malpractice litigation NOT recommended — statutes expired 30+ years ago, standard-of-care defense categorical | WA RCW 4.16.350, ORS 12.110(4) | N/A | HIGH | Multiple state statutes | 3 insurmountable barriers: repose, gradual onset, era-appropriate care |
| 9.6 | Hospital records from 1970s almost certainly destroyed (45-50yr retention gap) | WA WAC 246-08-390, OR OAR 333-505-0050 | N/A | HIGH | Regulatory analysis | Standard retention 7-20 years max |
| 9.7 | SSDI pathway available via Blue Book Listings 1.17/1.18 (reconstructive surgery, joint abnormality) | SSA.gov Blue Book | N/A | MODERATE | Regulatory guidance | Requires inability to ambulate effectively |
| 9.8 | Workers' Comp aggravation theory viable if work activities worsened pre-existing condition | Justia, PondLehocky | N/A | MODERATE | Legal analysis | Requires objective correlation between work and worsening |
| 9.9 | Surgical history can be reverse-engineered from current CT/MRI | ResearchGate 2024, clinical practice | V | MODERATE | Clinical expertise | Experienced foot/ankle surgeon can reconstruct likely procedures |
| 9.10 | Multiple surgeries worsen prognosis (Dobbs: single 78.4 vs multiple 64.8 functional score, p<0.005) | Dobbs et al. 2006 | III | HIGH | Single study | Key prognostic factor for salvage planning |
Domain 10 — Synthesis & Recommendations¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| 10.1 | Triple arthrodesis improves AOFAS by +25-43 points | Vietnam 2022, Zhuang 2019 | IV | MODERATE | Multiple retrospective series | AOFAS 40.6→83.8 in Vietnam study (p<0.01) |
| 10.2 | Triple arthrodesis recovery: 6-8wk NWB, mean 69 PT sessions, 9.6mo return to work | Maier 2023 | IV | MODERATE | Single case series | Range 3-34.5 months |
| 10.3 | Bilateral disease = no compensatory limb; accelerate decompensation | Domain synthesis | V | HIGH | Mechanistic reasoning | No comparative data exist |
| 10.4 | 57-67% of triple arthrodesis patients develop degenerative ankle changes | Zhuang 2019 (citing Ramseier) | IV | MODERATE | Within-review data | Important factor for combined fusion planning |
| 10.5 | Diabetes mellitus nonunion OR 1.71 (95% CI 1.06-2.76, p=0.028) in foot/ankle arthrodesis | Chiang et al. 2025, PMID 40082844 | II | EXTRAPOLATED | Population-based case-control | Not applicable to non-diabetic patient |
| 10.6 | TMT joint fusion: nonunion OR 6.51 (95% CI 1.05-40.52) in non-DM subgroup | Chiang et al. 2025, PMID 40082844 | II | MODERATE | Single study | Very wide CI; highest risk category |
| 10.7 | BMI has strong negative correlation (r=-0.738) with functional outcomes in arthrodesis | Maier 2023 | IV | MODERATE | Single case series (n=16) | Consider weight optimization before surgery |
| 10.8 | Sequential (not simultaneous) bilateral surgery recommended — 6-month interval | Domain synthesis | V | HIGH | Clinical consensus | Preserves mobility on one side |
| 10.9 | HBOT: mixed evidence; CMS coverage limited; may help if TcPO2 <30 mmHg | Multiple sources | IIb | LOW | Conflicting evidence | Best reserved for documented hypoxic wounds |
| 10.10 | No RCTs exist for adult post-clubfoot surgical complications | expert review 2026-05-16 | V | HIGH | Identified gap | Evidence systematically overstated—most labeled I-II actually Level IV |
Supplementary: Ponseti-Treated Adults¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| S.1 | Ponseti initial correction >90% in idiopathic clubfeet | Network meta-analysis, PMID 38015923 | I | HIGH | Meta-analysis 11 RCTs | Gold standard since ~2005-2010 |
| S.2 | Long-term Ponseti relapse rate: 47% at mean 14.5-year follow-up | PMID 34415418 | I | MODERATE | Systematic review 14 studies | 79% of relapsed patients needed additional surgery |
| S.3 | Ponseti late radiological changes: 60% talar flattening, 76% navicular wedging, 30% OA | PMID 34415418 | I | MODERATE | Systematic review | Disconnect between radiological findings and clinical function |
| S.4 | 15-year prospective: Ponseti superior to PMR (DSI 80.7 vs 65.6, p<0.05) | PMID 34547011 | II | HIGH | Prospective comparative study | PMR required more intra-articular procedures (15 vs 5, p<0.05) |
| S.5 | Ponseti: 76% excellent/good vs PMR: 45% at ~13-year follow-up | PMID 32982254 | III | MODERATE | Comparative study | ICFSG scoring system |
| S.6 | French method at 20 years: 80% good/excellent; <15% required surgery at walking age | PMID 33741833 | IV | LOW | Single retrospective case series | Higher compliance reported; higher cost and resource needs |
| S.7 | Network meta-analysis: Ponseti ranks best overall across multiple outcomes | PMID 38015923 | I | HIGH | 11 RCTs, 740 feet | Standard Ponseti best for Pirani, ROM, adverse events |
| S.8 | 10-year functional outcomes: all clubfoot groups have reduced ankle PF (9-14% ROM deficit, 13-23% power deficit, p<0.013) | PMID 30516624 | III | MODERATE | Prospective comparative | Clubfoot patients took 10% fewer steps (p=0.015) |
Supplementary: Arthrogrypotic Clubfoot¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| SA.1 | Arthrogrypotic clubfoot has fibrous muscle replacement, severe capsule contracture, neurogenic etiology | Hall 1997, PMID 9260643 | IV | MODERATE | Pathological studies | VERIFIED—exact match via PubMed |
| SA.2 | Morcuende 2008: Ponseti in arthrogryposis—93.75% initial correction (15/16), avg 7 casts | Morcuende 2008, Iowa Orthop J | IV | LOW | Single case series (n=16) | CORRECTED from claimed "78%" |
| SA.3 | van Bosse 2009: modified Ponseti in arthrogryposis—78.9% satisfactory (15/19 ft) | van Bosse 2009, Clin Orthop Relat Res | IV | LOW | Single case series (n=10) | CORRECTED from claimed "67%" and wrong year/journal |
| SA.4 | Matar 2016: 100% initial correction Ponseti in arthrogryposis; 64.7% satisfactory at 5.8yr | Matar 2016, J Child Orthop | IV | LOW | Single case series (n=10) | CORRECTED from claimed "50%"—100% is actual |
| SA.5 | Banskota et al. (2015) — FABRICATED reference — does not exist in PubMed | N/A | — | — | — | Entirely fabricated citation removed |
Supplementary: Emerging & Experimental Treatments (abbreviated page)¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| SE.1 | NPWT/VAC: widely available, strong evidence for DFU (Class I); used off-label for structural wounds | Multiple | I | EXTRAPOLATED | Strong evidence in DFU | Standard of care in wound management |
| SE.2 | PRP: moderate evidence, multiple meta-analyses | Multiple | III | MODERATE | Multiple studies | Autologous, low-risk |
| SE.3 | CAP: moderate evidence (1 RCT + emerging) | NCT06964048 | IIb | MODERATE | Emerging | Clinical trials active |
| SE.4 | Stem cell therapy: moderate evidence (umbrella review) | 2025 umbrella review | IIb | MODERATE | Umbrella review | Phase I-II trials |
| SE.5 | Exosome therapy: weak evidence (recent retraction; mixed quality) | PMC12494051 (retracted) | V | LOW | Limited/retracted | Caution advised—unregulated market |
Supplementary: French Functional Method¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| SF.1 | Richards 2008: Ponseti 94.4% vs French 95% initial correction (n=386, prospective) | Richards et al. 2008 | III | MODERATE | Single prospective study | CORRECTED: wiki previously claimed 96% vs 79%—all statistics fabricated |
| SF.2 | Seringe 1990: 269 feet treated with French method | Seringe et al. 1990 | IV | MODERATE | Single case series | CORRECTED from claimed 127 or 145 feet |
| SF.3 | Bonnet 2005 — FABRICATED reference; no such author exists in PubMed clubfoot literature | N/A | — | — | — | Correct author: Frédérique Bonnet (Bonnet F) |
| SF.4 | Zionts 2014 — FABRICATED reference; Zionts' 2014 publications were on tendon transfer biomechanics, not conservative method comparison | N/A | — | — | — | No such literature review exists |
Supplementary: Courses of Action¶
| # | Claim Text | Supporting Citation(s) | OCEBM Level | Confidence | Replication | Notes |
|---|---|---|---|---|---|---|
| COA.1 | Conservative pathway: offloading (TCC) + custom orthotics + PT + pain management | Clinical consensus | V | HIGH | Standard approach | First-line for all patients |
| COA.2 | Surgical pathway: triple arthrodesis is gold standard for rigid deformity | Domain 4 synthesis | IV | MODERATE | Multiple case series | 81-100% satisfaction, 10-11% nonunion |
| COA.3 | External fixation pathway: Ilizarov/TSF for severe multiplanar deformity | Domain 4 synthesis | IV | MODERATE | Meta-analysis of case series | Higher complication profile (pin tract 19.6-27%) |
| COA.4 | Amputation pathway: BKA if salvage impossible (LEAP: outcomes similar at 2yr) | LEAP study | II | EXTRAPOLATED | Multicenter prospective | Delayed BKA patients function worse at 4-5yr |
| COA.5 | Bilateral disease requires sequential surgery (6-month interval) | Clinical consensus | V | HIGH | Standard approach | NOT simultaneous |
Summary Statistics¶
| Metric | Count |
|---|---|
| Total clinical claims extracted | 120+ |
| OCEBM Level I | ~12 |
| OCEBM Level II | ~10 |
| OCEBM Level III | ~20 |
| OCEBM Level IV | ~35 |
| OCEBM Level V | ~25 |
| N/A (legal/regulatory) | ~8 |
| Confidence: HIGH | ~30 |
| Confidence: MODERATE | ~45 |
| Confidence: LOW | ~12 |
| Confidence: EXTRAPOLATED | ~25 |
| Claims from diabetic/general populations (extrapolated) | ~25 |
| Fabricated citations identified and corrected | ~6 |
| Identified research gaps | ~15 |
Key Findings¶
-
Highest-quality evidence (Level I): Ponseti meta-analyses, network meta-analysis (PMID 38015923), electrical stimulation Cochrane review, pregabalin vs gabapentin meta-analysis, TOT guideline endorsements.
-
Most actionable claims: Triple arthrodesis as gold-standard salvage (Level IV, multiple series), PMR 30-year outcomes (Level III, Dobbs 2006), TCC offloading efficacy (Level II in DFU, extrapolated).
-
Critical evidence gaps: No RCTs for adult post-clubfoot surgical complications; no vascular outcome studies in non-diabetic post-surgical foot wounds; no prospective Ponseti cohort followed past age 30; no adult clubfoot-specific rehab protocols; no dedicated adult clubfoot registry.
-
Extrapolation caution: ~25 claims are extrapolated from diabetic foot ulcer, CLTI, stroke, or general neuropathic pain populations. While mechanistic rationale supports transfer, formal studies in post-surgical clubfoot patients are absent.
-
Citation integrity: 6+ fabricated citations identified (Banskota, Bonnet 2005, Zionts 2014, General literature 2025, etc.). All corrected with actual source data or removed. The wiki has undergone systematic citation audit across all domains.
Evidence matrix compiled: 2026-05-20Sources: 10 domain files + 5 supplementary files from ~/wiki/wiki/tev/Method: Full-text read of ~6,400 lines across 15 files; Oxford CEBM 2011 grading; confidence rating per applicability to adult post-surgical clubfoot population